Topic: Pharmaceuticals and life sciences

Subscribe to Pharmaceuticals and life sciences RSS feed

Confronting the mid-market M&A valuation gap

Firmex and Mergermarket recently published a report entitled Mid-Market M&A: The Valuation Gap (the Report), which explores valuation challenges that buyers and sellers are facing in mid-market M&A. According to Mergermarket data, the number and value of American and Canadian mid-market M&A deals (US$10m to $250m in value) slipped year-on-year, with the slump continuing into … Continue reading

Medical marijuana M&A in Canada: update

In October 2015, companies engaged in the licensed production and sale of marijuana welcomed the victory of pro-decriminalization candidate Justin Trudeau. Exactly what the victory meant for the heavily regulated industry was unclear but several publicly traded companies enjoyed an immediate rise in stock prices as the potential size of the market expanded significantly. In … Continue reading

An overview of global M&A activity: 2015 into 2016

2015 was an extraordinary year for global M&A activity. Mergermarket recorded almost 17,000 transactions worth a remarkable US$4.3tn. This topped the previous record set in 2014 by over 30%. The race for top performing sector this year was very close. Energy Mining & Utilities won with US$630bn in deal value; however, the top performers were … Continue reading

Year in review: deal drivers in the Americas in 2015

Mergermarket recently released its 2015 full-year edition of Deal Drivers Americas (the Review). This comprehensive review of M&A activity in the Americas confirmed that 2015 was a year of mega-deals. Transactions involving giants such as Pfizer, Time Warner Cable, and Kraft contributed to an increase of 30% in M&A value, reaching a total of US$4.28 … Continue reading

New Year’s resolution: buying & selling smart

2015 was a huge year for global M&A with deal activity reaching $4.2 trillion by the middle of December.  If 2016 continues at the same pace, be prepared for a big year of M&A activity. In order to be well equipped for the upcoming year, ask yourself the following two questions when contemplating an M&A … Continue reading

M&A trends for 2016

The last 18 months has seen a rebirth in M&A. For the first time since the 2008 financial crisis, deal activity has reached pre-recession levels. This has been fueled by low interest rates, high equity prices and capital availability. CDI Global’s Managing director, Jeff Schmidt, has gone on the record stating that while it’s hard … Continue reading

A global overview of December 2015 M&A activity

According to Mergermarket’s December insider, November 2015 was a record setting month for M&A activity. By the end of the month, global M&A value reached US$3.9tn which surpassed the 2007 full year record by almost 6%. This record came on a drop in volume by 1,228 transactions which further cements 2015 as the year of … Continue reading

Life sciences M&A sees new heights in 2015

2015 continues to see record-setting activity in both the frequency and value of M&A deals involving pharmaceutical companies, and generally in the life-sciences sector. According to a report published by PricewaterhouseCoopers, the combined value of closed M&A deals in the life-sciences and pharmaceutical sector surpassed USD $320Bn in the first three quarters of 2015. Further, … Continue reading

Thomson Reuters reports healthy global M&A through Q3 2015

In its Global M&A Review, for the first nine months of 2015, Thomson Reuters reports healthy global M&A activity leading into the final quarter of fiscal 2015. The study reports increases in both deal value and deal volume across most jurisdictions and industry sectors. Global increase in both deal volume and deal value Thomson Reuters … Continue reading

M&A activity in the pharmaceutical sector is driving the commercialization of new drugs

The global pharmaceutical sector has been rocked by several significant mergers and acquisitions in 2015: Indian generics firm Sun Pharma purchased GSK’s Australian opiates operations, citing the development of analgesics as a key growth opportunity US-based AbbVie acquired Pharmacyclics, with a central motivation being the acquisition of the blockbuster cancer drug Imbruvica US giant Pfizer … Continue reading

M&A in Canada: industry revenue and profits

Expanding growth in nearly all sectors Norton Rose Fulbright focuses its services on 6 key industry sectors and, according to a study released recently by the Globe and Mail on Canadian corporations, almost all of these sectors have seen an expansion in revenue and most have seen growth in profits during the period from 2011 to … Continue reading

Cross-border and private equity activity in Q2 2015

As we move towards the end of the second quarter of 2015, many have wondered whether this year will be able to live up to the bumper year of 2014 in terms of cross-border private equity activity. Despite volatile commodity prices and an unsteady European market, a recent survey conducted by integrated communications firm RR Donnelley revealed … Continue reading

2015 is the year of technology M&A

In recent years past, global technology M&A experienced slow first quarters. But not this year – the first quarter of 2015 set new post-dotcom-bubble records for quarterly value and volume according to EY’s report on Global technology M&A. Overall, there were 981 technology deals with an aggregate value of US $77.1 billion – a higher … Continue reading

M&A in Q1 2015: the results are in

The Mergermarket Group has published its Monthly M&A Insider – April 2015 report outlining trends and developments in M&A activity worldwide for the first quarter of 2015. In North America, M&A activity continued on the upward trend set in 2014. The first quarter saw 1,116 deals valued at US $338.8 billion, which was a 11% … Continue reading

M&A growth predictions for 2015

Forbes contributor, Michael Schwerdtfeger, recently commented that “2014’s dynamic merger & acquisition market is galloping right into 2015.” Citing various sources, he notes that 2014 was the strongest year for deal-making since at least 2008, with a 47% increase over last year. The overall value of deals in North America grew by nearly 55% due … Continue reading

Sophisticated hackers may be trading with stolen M&A data

A recent report by security consulting firm FireEye reveals that a hacker group, referred to as FIN4, have infiltrated over 100 publicly traded companies and advisory firms since at least mid-2013 and are likely trading using inside information. FIN4’s ongoing hacking efforts particularly target the email accounts of individuals with access to non-public information about … Continue reading

Looking back on 2014: regional trends in global M&A

A look back on deal activity in 2014 undertaken by Mergermarket in its December 2014 Monthly M&A Insider reveals that North America dominated global deal value last year, hosting 48.1% of the value. Europe was next, with 27.3% of global deal value, but surpassed North America, dominating the global M&A scene in terms of deal … Continue reading

Pharmaceutical M&A: strong performance expected to continue in 2015

In its December 2014 cover story, Financier Worldwide provides an overview of the factors in 2014 that provided, and will continue to provide, favorable conditions for the high value and volume of pharmaceutical mergers and acquisitions. In the first half of 2014 alone, there was a total value of $317.4 billion USD in M&A deals. … Continue reading

M&A: a leading growth strategy in 2015

The economic fundamentals that drive M&A are back at pre-crisis levels, states a new survey published by KPMG. The number of acquisitions that companies will undertake is expected to increase in 2015: 82% of respondents plan at least one acquisition and 10% anticipate 11 or more acquisitions next year. Indeed, the survey suggests M&A is … Continue reading

More and bigger: Global and North American M&A market update

The 2014 trend of high value deals continues, according to a recently released Mergermarket Monthly M&A Insider report on global M&A activity. Through the month of October, the aggregate value of deals worldwide for the year has surpassed the last year’s total. Volume, on the other hand, still has some way to go before matching … Continue reading

The M&A revival and other recent developments

Mergermarket just released the half-year edition of its 2014 Deal Drivers Americas (DDA) report, and it looks like a year full of clear skies and sunshine for the M&A market – in other words, the long-awaited revival is here. Trends in private equity activity in the Americas Looking at the DDA report, we see that … Continue reading

M&A activity continues to rise in Q2 2014

Recent reports by Mergermarket and Pricewaterhouse Coopers (PwC) have confirmed the positive forecasts for M&A transactions in Q2 2014.  Globally, deal volume has reached its highest level since 2007.  North America, in particular, has seen a strong amount of activity with a number of megadeals listed in the top 10 deals in the world. North … Continue reading

Early-stage deals signal growth in global M&A for 2014

Intralinks publishes a Deal Flow Indicator (“DFI”) report on a quarterly basis with a view to predicting global M&A trends based on comprehensive tracking of early-stage M&A deals across the world. According to its recently released Q2 2014 DFI report, Intralinks predicts that 2014 is poised to end on a strong note for M&A activity. … Continue reading

International business report says M&A market set to enter busy phase

Grant Thornton LLP recently published its annual International Business Report (the Report). The Report, which aims to chart appetite for M&A around the world, is based on interviews with more than 12,500 chief executive officers, managing directors, chairmen and other senior decision-makers across all sectors. The Report’s findings, while varied, all point to the importance … Continue reading
LexBlog